Fuse Science, Inc. Logo

Fuse Science, Inc.

DROP

(1.8)
Stock Price

0,00 USD

-23145.98% ROA

20.39% ROE

-0x PER

Market Cap.

800.000,00 USD

0% DER

0% Yield

8.76% NPM

Fuse Science, Inc. Stock Analysis

Fuse Science, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Fuse Science, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (396.91%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (-0x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

4 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

5 ROA

The stock's ROA (-23145.98%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Fuse Science, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Fuse Science, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Fuse Science, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Fuse Science, Inc. Revenue
Year Revenue Growth
1997 7.830.844
1998 12.800.000 38.82%
1999 14.200.000 9.86%
2000 1 -1419999900%
2001 3.321.392 100%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 318 100%
2008 64.402 99.51%
2009 2.567 -2408.84%
2010 8.800 70.83%
2011 0 0%
2012 105.413 100%
2013 486.763 78.34%
2014 448.627 -8.5%
2015 0 0%
2016 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Fuse Science, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1997 265.466
1998 500.000 46.91%
1999 900.000 44.44%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 204.541 100%
2013 2.200 -9197.32%
2014 177.653 98.76%
2015 52.264 -239.91%
2016 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Fuse Science, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 33.519 100%
2008 183.039 81.69%
2009 45.022 -306.55%
2010 35.003 -28.62%
2011 1.614.307 97.83%
2012 4.118.264 60.8%
2013 6.398.060 35.63%
2014 3.065.428 -108.72%
2015 3.575.228 14.26%
2016 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Fuse Science, Inc. EBITDA
Year EBITDA Growth
1997 3.536.720
1998 4.400.000 19.62%
1999 1.000.000 -340%
2000 -80.999 1334.58%
2001 -487.537 83.39%
2002 -34.432 -1315.94%
2003 -366.527 90.61%
2004 -567.359 35.4%
2005 -432.875 -31.07%
2006 -405.612 -6.72%
2007 13.799 3039.43%
2008 -259.607 105.32%
2009 -122.097 -112.62%
2010 2.477 5029.23%
2011 -1.244.344 100.2%
2012 -6.586.096 81.11%
2013 -8.830.581 25.42%
2014 -5.380.152 -64.13%
2015 -4.012.713 -34.08%
2016 0 0%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Fuse Science, Inc. Gross Profit
Year Gross Profit Growth
1997 4.155.333
1998 7.500.000 44.6%
1999 5.800.000 -29.31%
2000 1 -579999900%
2001 507.981 100%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 -2.682 100%
2008 21.402 112.53%
2009 -83.341 125.68%
2010 -3.200 -2504.41%
2011 0 0%
2012 74.179 100%
2013 310.777 76.13%
2014 -975.946 131.84%
2015 0 0%
2016 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Fuse Science, Inc. Net Profit
Year Net Profit Growth
1997 1.476.346
1998 2.000.000 26.18%
1999 300.000 -566.67%
2000 -6.796.862 104.41%
2001 -304.627 -2131.21%
2002 -1.340.119 77.27%
2003 -525.599 -154.97%
2004 -657.961 20.12%
2005 -433.492 -51.78%
2006 -406.668 -6.6%
2007 -93.736 -333.84%
2008 -63.667 -47.23%
2009 -153.061 58.4%
2010 -80.348 -90.5%
2011 -2.020.161 96.02%
2012 -11.042.438 81.71%
2013 -21.368.353 48.32%
2014 -7.695.607 -177.67%
2015 -26.575.986 71.04%
2016 0 0%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Fuse Science, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1997 54.679
1998 71.309 23.32%
1999 7.920 -800.35%
2000 -178.865 104.43%
2001 -7.084 -2424.9%
2002 -31.166 77.27%
2003 -11.945 -160.9%
2004 -13.428 11.04%
2005 -8.847 -51.79%
2006 -6.778 -30.53%
2007 -68 -9866.18%
2008 -3 -2166.67%
2009 -6 50%
2010 -3 -100%
2011 -59 94.92%
2012 -182 67.58%
2013 -162 -13.04%
2014 -33 -403.13%
2015 -114 71.68%
2016 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Fuse Science, Inc. Free Cashflow
Year Free Cashflow Growth
1997 17.623
1998 2.200.000 99.2%
1999 -5.300.000 141.51%
2000 -6.715.862 21.08%
2001 -568.703 -1080.91%
2002 -201.750 -181.89%
2003 -1.716.671 88.25%
2004 978.712 275.4%
2005 -232.796 520.42%
2006 -283.718 17.95%
2007 -36.205 -683.64%
2008 -590.864 93.87%
2009 -20.304 -2810.09%
2010 -46.613 56.44%
2011 -810.928 94.25%
2012 -4.511.174 82.02%
2013 -5.119.074 11.88%
2014 -1.826.418 -180.28%
2015 -1.525.667 -19.71%
2016 1.335.306 214.26%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Fuse Science, Inc. Operating Cashflow
Year Operating Cashflow Growth
1997 1.843.968
1998 2.600.000 29.08%
1999 1.800.000 -44.44%
2000 -6.715.862 126.8%
2001 -542.505 -1137.94%
2002 -200.161 -171.03%
2003 -1.716.671 88.34%
2004 1.001.634 271.39%
2005 -232.796 530.26%
2006 -283.718 17.95%
2007 -36.205 -683.64%
2008 -590.864 93.87%
2009 -20.304 -2810.09%
2010 -46.613 56.44%
2011 -760.928 93.87%
2012 -4.418.294 82.78%
2013 -5.053.007 12.56%
2014 -1.808.833 -179.35%
2015 -1.520.520 -18.96%
2016 1.335.306 213.87%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Fuse Science, Inc. Capital Expenditure
Year Capital Expenditure Growth
1997 1.826.345
1998 400.000 -356.59%
1999 7.100.000 94.37%
2000 0 0%
2001 26.198 100%
2002 1.589 -1548.71%
2003 0 0%
2004 22.922 100%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 50.000 100%
2012 92.880 46.17%
2013 66.067 -40.58%
2014 17.585 -275.7%
2015 5.147 -241.66%
2016 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Fuse Science, Inc. Equity
Year Equity Growth
1997 3.581.437
1998 5.800.000 38.25%
1999 5.400.000 -7.41%
2000 1.419.000 -280.55%
2001 2.429.711 41.6%
2002 1.107.456 -119.4%
2003 682.432 -62.28%
2004 64.210 -962.81%
2005 -294.829 121.78%
2006 -37.946 -676.97%
2007 -185.282 79.52%
2008 970.880 119.08%
2009 -69.556 1495.82%
2010 -181.446 61.67%
2011 -656.819 72.38%
2012 -470.757 -39.52%
2013 -661.471 28.83%
2014 -2.302.075 71.27%
2015 -831.944 -176.71%
2016 0 0%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Fuse Science, Inc. Assets
Year Assets Growth
1997 5.379.657
1998 8.100.000 33.58%
1999 12.100.000 33.06%
2000 2.356.417 -413.49%
2001 3.131.114 24.74%
2002 1.169.870 -167.65%
2003 1.519.774 23.02%
2004 265.119 -473.24%
2005 172.831 -53.4%
2006 0 0%
2007 123.169 100%
2008 1.012.885 87.84%
2009 237.896 -325.77%
2010 69.425 -242.67%
2011 342.408 79.72%
2012 799.615 57.18%
2013 1.645.875 51.42%
2014 11.880 -13754.17%
2015 118.449 89.97%
2016 0 0%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Fuse Science, Inc. Liabilities
Year Liabilities Growth
1997 1.798.220
1998 2.300.000 21.82%
1999 6.700.000 65.67%
2000 937.417 -614.73%
2001 701.403 -33.65%
2002 62.414 -1023.79%
2003 837.342 92.55%
2004 200.909 -316.78%
2005 467.660 57.04%
2006 37.946 -1132.44%
2007 308.451 87.7%
2008 42.005 -634.32%
2009 307.452 86.34%
2010 250.871 -22.55%
2011 999.227 74.89%
2012 1.270.372 21.34%
2013 2.307.346 44.94%
2014 2.313.955 0.29%
2015 950.393 -143.47%
2016 0 0%

Fuse Science, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-113.67
Price to Earning Ratio
-0x
Price To Sales Ratio
0x
POCF Ratio
-0
PFCF Ratio
-0.52
Price to Book Ratio
-0
EV to Sales
0
EV Over EBITDA
-0.17
EV to Operating CashFlow
-0.46
EV to FreeCashFlow
-0.46
Earnings Yield
-11366.63
FreeCashFlow Yield
-1.91
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
350.26
Graham NetNet
-3.62

Income Statement Metrics

Net Income per Share
-113.67
Income Quality
0.06
ROE
3.97
Return On Assets
0.18
Return On Capital Employed
0.18
Net Income per EBT
1
EBT Per Ebit
1
Ebit per Revenue
0.09
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
1
Operating Profit Margin
0.09
Pretax Profit Margin
0.09
Net Profit Margin
0.09

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-6.5
Free CashFlow per Share
-6.53
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
-1.45
Return on Invested Capital
2.22
Return on Tangible Assets
-231.46
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
-0.02

Balance Sheet

Cash per Share
0,42
Book Value per Share
-47,97
Tangible Book Value per Share
-3.57
Shareholders Equity per Share
-47.97
Interest Debt per Share
1.22
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.02
Current Ratio
0.15
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.03
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
2716.5
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Fuse Science, Inc. Dividends
Year Dividends Growth

Fuse Science, Inc. Profile

About Fuse Science, Inc.

Fuse Science, Inc. operates a cloud-based customer service software platform. The company also produces and sells sports nutrition and performance products. Its products include SkyPorts, a drone support technology and energy demand network that enables long distance flight required for drone-based commerce without the need for drones to return every 15 minutes to recharge; and XTRAX, a remote monitoring system designed to measure the production of solar and other renewable energy systems, as well as transmit the data via the cellular and radio frequency. The company was formerly known as Double Eagle Holdings, Ltd. and changed its name to Fuse Science, Inc. in December 2011. Fuse Science, Inc. was incorporated in 1988 and is based in Jacksonville, Florida.

CEO
Mr. David Delke
Employee
0
Address
25 N.orth Market Street
Jacksonville, 32202

Fuse Science, Inc. Executives & BODs

Fuse Science, Inc. Executives & BODs
# Name Age
1 Mr. David Delke
President
70

Fuse Science, Inc. Competitors

LiveToBeHappy, Inc. Logo
LiveToBeHappy, Inc.

CAVR

(0.0)
Epazz, Inc. Logo
Epazz, Inc.

EPAZ

(1.8)
Pervasip Corp. Logo
Pervasip Corp.

PVSP

(1.8)
GRILLiT, Inc. Logo
GRILLiT, Inc.

GRLT

(1.8)